Literature DB >> 8478087

Bacteria induce release of platelet-activating factor (PAF) from polymorphonuclear neutrophil granulocytes: possible role for PAF in pathogenesis of experimentally induced bacterial pneumonia.

A Makristathis1, F Stauffer, S M Feistauer, A Georgopoulos.   

Abstract

The role of platelet-activating factor (PAF) as mediator of the endotoxin shock and endotoxin-dependent tissue injury has been examined. The ability of opsonized bacteria to stimulate the release of PAF from human polymorphonuclear neutrophil granulocytes was evaluated by measuring both the activity and the amount of the mediator released in the supernatant of the cell-bacteria reaction in vitro. There was no significant difference between gram-positive and gram-negative bacteria in the ability to release PAF from neutrophils. However, preincubation of the cells with the specific PAF receptor antagonist WEB 2170 decreased release of PAF from the cells. Furthermore, a possible protective effect of the PAF antagonist was examined during experimentally induced pneumonia with Klebsiella pneumoniae in NMRI mice. Oral treatment of mice with WEB 2170, followed by infection with the microorganisms, resulted in a considerable increase in the animals' survival (53 to 73%) compared with the control group (40%); this increase corresponded with a decrease in the CFU per gram of lung tissue. These findings indicate an important role of PAF in the pathogenesis of pneumonia in mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8478087      PMCID: PMC280794          DOI: 10.1128/iai.61.5.1996-2002.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.

Authors:  H O Heuer; J Casals-Stenzel; G Muacevic; K H Weber
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

2.  Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.

Authors:  G Camussi; M Aglietta; R Coda; F Bussolino; W Piacibello; C Tetta
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

3.  Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF).

Authors:  T Yasaka; L A Boxer; R L Baehner
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

4.  Human neutrophil-derived platelet activating factor.

Authors:  G Z Lotner; J M Lynch; S J Betz; P M Henson
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

5.  Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation.

Authors:  G Camussi; C Tetta; F Bussolino; F Caligaris Cappio; R Coda; C Masera; G Segoloni
Journal:  Int Arch Allergy Appl Immunol       Date:  1981

6.  Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine.

Authors:  S R Findlay; L M Lichtenstein; D J Hanahan; R N Pinckard
Journal:  Am J Physiol       Date:  1981-09

7.  Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine.

Authors:  F H Chilton; J T O'Flaherty; C E Walsh; M J Thomas; R L Wykle; L R DeChatelet; B M Waite
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

8.  Early bacterial clearance from murine lungs. Species-dependent phagocyte response.

Authors:  S R Rehm; G N Gross; A K Pierce
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

9.  Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).

Authors:  J O Shaw; R N Pinckard; K S Ferrigni; L M McManus; D J Hanahan
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

10.  Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.

Authors:  J Benveniste; P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  4 in total

1.  Role of the platelet-activating factor (PAF) receptor during pulmonary infection with gram negative bacteria.

Authors:  A C Soares; V S Pinho; D G Souza; T Shimizu; S Ishii; J R Nicoli; M M Teixeira
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  Lipoxin A4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice.

Authors:  Haiya Wu; Jun Yang; Emily M Su; Ling Li; Caiqi Zhao; Xi Yang; Zhaowei Gao; Mengyao Pan; Peiyu Sun; Wei Sun; Yiyi Jiang; Xiao Su
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

3.  Cigarette smoke promotes COPD by activating platelet-activating factor receptor and inducing neutrophil autophagic death in mice.

Authors:  Xiao-Xi Lv; Shan-Shan Liu; Ke Li; Bing Cui; Chang Liu; Zhuo-Wei Hu
Journal:  Oncotarget       Date:  2017-08-18

4.  Bacterial clearance is improved in septic mice by platelet-activating factor-acetylhydrolase (PAF-AH) administration.

Authors:  Mariana G A Teixeira-da-Cunha; Rachel N Gomes; Nathassia Roehrs; Fernando A Bozza; Stephen M Prescott; Diana Stafforini; Guy A Zimmerman; Patricia T Bozza; Hugo C Castro-Faria-Neto
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.